Edition:
United Kingdom

Spring Bank Pharmaceuticals Inc (SBPH.OQ)

SBPH.OQ on NASDAQ Stock Exchange Capital Market

11.54USD
2:49pm GMT
Change (% chg)

$-0.12 (-1.03%)
Prev Close
$11.66
Open
$11.74
Day's High
$11.74
Day's Low
$11.54
Volume
404
Avg. Vol
9,021
52-wk High
$18.93
52-wk Low
$7.95

Chart for

About

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of a class of therapeutics using its small molecule nucleic acid hybrid (SMNH) chemistry platform. The Company is developing its SMNH product, SB 9200, for the treatment of viral diseases. The... (more)

Overall

Beta: --
Market Cap(Mil.): $208.23
Shares Outstanding(Mil.): 12.70
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Spring Bank Pharmaceuticals Reports Q4 Loss Per Share $0.11

* SPRING BANK PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL AND OPERATIONAL RESULTS

20 Feb 2018

BRIEF-Spring Bank Pharmaceuticals announces positive top-line results from the second cohort of part A of the phase 2 achieve trial

* Spring Bank Pharmaceuticals announces positive top-line results from the second cohort of part A of the phase 2 achieve trial

15 Nov 2017

Earnings vs. Estimates